Ardelyx stock rockets on heavy volume after positive FDA panel vote on kidney disease treatment

Shares of Ardelyx Inc. ARDX, +35.66% rocketed 75.4% on heavy volume toward a 16-month high in premarket trading Thursday, after an advisory panel of the U.S. Food and Drug Administration voted that be...